Taiwan FDA registration ed6ff1f14e70197212093854b2f13734
Yilimei blood glucose/cholesterol/heme monitoring system
TW: 易立測 血糖/膽固醇/血紅素 監測系統
Taiwan·Risk Class 2·Naohara Biotechnology Co., Ltd.;; Yuxin Biotechnology Co., Ltd·Registered Jul 30, 2018 – Jul 30, 2028ActiveRegistration details
- Analysis ID
- ed6ff1f14e70197212093854b2f13734
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- EASY LIFE GREEN TECHNOLOGY CORPORATION
Product details
- Intended Use
- This product is only for in vitro testing, measured with fresh fingertip microvascular whole blood to quantitatively detect blood sugar, cholesterol and heme content. This product can be used by self-testing and professionals, but is not intended for testing of newborns.
- Product Type (Level 1)
- B Haematology, pathology and genetics; A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System;; B.7500 Heme analysis of whole blood;; A.1175 Cholesterol (Total) Testing System
- Import Information
- Contract manufacturing;; Domestic
Dates and status
- Registration Date
- Jul 30, 2018
- Expiry Date
- Jul 30, 2028
About this record
Access comprehensive regulatory information for Yilimei blood glucose/cholesterol/heme monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ed6ff1f14e70197212093854b2f13734 and manufactured by Naohara Biotechnology Co., Ltd.;; Yuxin Biotechnology Co., Ltd. The authorized representative in Taiwan is EASY LIFE GREEN TECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices